Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival
Authors:
- 2 April 2020
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 181 (1) , 23-29
Abstract
Purpose Pleomorphic invasive lobular carcinoma (ILC) has long been thought to have worse outcomes than classic ILC and is therefore often treated with chemotherapy. However, recent data question the utility of the pleomorphic designation, as the poor outcomes seen may be related to other associated high-risk features. Importantly, mitotic count may better define a subset of ILC with high risk of recurrence. We sought to determine the impact of pleomorphic histology versus mitotic count on disease-free survival (DFS) in pure ILC. Additionally, we evaluated whether pleomorphic histology was associated with receipt of chemotherapy when adjusting for other factors. Methods We analyzed a cohort of 475 patients with stage I–III pure ILC. We used Kaplan–Meier estimates, and Cox proportional hazards and logistic regression for multivariate analyses. Pleomorphic histology was confirmed by central pathology review. Results In a multivariate model, pleomorphic histology was not associated with reduced DFS. Only mitotic score, receptor subtype, and pathologic stage were independently and significantly associated with DFS. Patients with pleomorphic ILC were significantly more likely to receive chemotherapy than patients with classic ILC (adjusted odds ratio 2.96, p = 0.026). Conclusions The pleomorphic designation in ILC does not have clinical utility and should not be used to determine therapy. Rather, mitotic count identified clear prognostic groups in this cohort of pure ILC.Keywords
This publication has 25 references indexed in Scilit:
- Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinomaBreast Cancer Research and Treatment, 2014
- Pleomorphic lobular carcinoma of the breast: is it a prognostically significant pathological subtype independent of histological grade?Laboratory Investigation, 2013
- Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancerBreast Cancer Research and Treatment, 2012
- Inhibition of pulmonary metastasis in a human MT3 breast cancer xenograft model by dual liposomes preventing intravasal fibrin clot formationBreast Cancer Research and Treatment, 2009
- Is pleomorphic lobular carcinoma really a distinct clinical entity?Journal of Surgical Oncology, 2008
- Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomasThe Journal of Pathology, 2008
- REporting recommendations for tumour MARKer prognostic studies (REMARK)British Journal of Cancer, 2005
- Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entityThe Journal of Pathology, 2005
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Infiltrating lobular carcinoma of the breastHistopathology, 1982